The most significantly increased risk for ESCC risk (OR: 13.46; 95% CI: 2.32–78.07, p<0.001) was noted in individuals with ADH1B Arg+ and ALDH2 Lys+. This evidence concerns the gene ADH1B and esophageal squamous cell carcinoma.